摘要
慢性阻塞性肺疾病(COPD)是一种危害人类健康乃至生命的严重慢性呼吸系统疾病,亟需引起全社会的高度重视,并需多方通力协作,共同提升并优化对COPD的规范管理。由于罹患COPD者始终伴随着药物的治疗,药师的参与就显得尤为重要,也具有显著的必要性。本研究在剖析我国目前COPD管理现状的基础上,找到影响治疗目标的重要环节,即认知程度低、用药不规范、依从性差和急性加重报告不足等;根据国内外药师干预后取得的诸多令人鼓舞的临床获益,进一步呈现药师在优化COPD管理中的价值;探寻药师参与并助力COPD管理的四大工作切入点,即一级预防、早期发现、用药支持、监测随访,并建议通过积极推进并完善COPD医药联合门诊工作、积极向基层渗透等方面进一步提升我国COPD管理水平及效果,为我国COPD的规范管理提供借鉴,并为药师在慢病诊治过程中的工作模式提供参考。
Chronic obstructive pulmonary disease(COPD) is a severe chronic respiratory disease that endangers human health and even life, which is urgent to arouse the attention of the whole society. Multi-party cooperation is required to enhance and optimize the standard management of COPD. As COPD patients receive medication from the beginning to the end, the participation of pharmacists is quite important and necessary. On the basis of current situation of COPD management in China, the important links affecting COPD therapeutic goals, including low level of cognition, irregular use of drugs, poor compliance and underreporting of acute exacerbations, were explored in this article. According to various inspiring clinical benefits obtained after domestic and foreign pharmacists’ intervention, the values of pharmacists in optimizing COPD management were further reflected.The four working entry points of pharmacists participating in and assisting COPD management were searched,including primary prevention, early detection, medication support and monitoring follow-up. Moreover, MDT combined clinic for COPD should be actively promoted and improved, and penetration to the base should also be strengthened in order to enhance the management level and effect of COPD in our country. These results are helpful to the COPD standard management in China and could provide references for the working mode establishement of pharmacists in chronic diseases.
作者
汤超
何文
Tang Chao;He Wen(Xiantao First People’s Hospital,Xiantao 433000,China;Renmin Hospital of Wuhan University,Wuhan 430060,China)
出处
《中国药事》
CAS
2022年第1期105-111,共7页
Chinese Pharmaceutical Affairs
